Article

Chronic fibrosing cholangiopathies: A consequence of a defective HCO(3)(-) "umbrella"?

University of Paris 7, Paris, France.
Gastroentérologie Clinique et Biologique (impact factor: 0.8). 01/2011; DOI:10.1016/j.clinre.2010.10.005
Source: PubMed

ABSTRACT The pathogenesis of chronic cholangiopathies, in particular primary biliary cirrhosis and primary sclerosing cholangitis, is still obscure. A stimulating hypothesis is proposed by Beuers et al. They reason that, since cholangiocytes are exposed to high concentrations of hydrophobic bile salts that are toxic at μM concentrations, these cells had to develop protective mechanisms. Apart from micelle formation, the authors argue that biliary HCO(3)(-) secretion serves to maintain an alkaline pH near the apical surface of cholangiocytes by forming a HCO(3)(-) "umbrella". In this alkaline environment, glycine conjugated bile salts (which are predominant in man), with a pK(a) of ∼4, remain deprotonated and are unable to permeate the apical membrane and cause cell damage. Functional impairment of biliary HCO(3)(-) secretion leads to enhanced vulnerability of cholangiocytes toward the attack of hydrophobic bile salts, causing cell damage and cholangitis. Such an impairment could be due to genetic factors, like mutations of the anion exchanger 2 (a variant of the Cl(-)/HCO(3)(-) exchanger) in primary biliary cirrhosis or of TGR5 (a bile salt receptor implicated in the regulation of HCO(3)(-) secretion) in primary sclerosing cholangitis. This stimulating hypothesis is amenable to experimental testing and has potential pathophysiological and therapeutic implications.

0 0
 · 
0 Bookmarks
 · 
45 Views

Keywords

alkaline pH
 
anion exchanger 2
 
apical membrane
 
apical surface
 
bile salt receptor
 
cause cell damage
 
cell damage
 
chronic cholangiopathies
 
experimental testing
 
Functional impairment
 
genetic factors
 
glycine conjugated bile salts
 
hydrophobic bile salts
 
micelle formation
 
potential pathophysiological
 
primary biliary cirrhosis
 
primary sclerosing cholangitis
 
protective mechanisms
 
stimulating hypothesis
 
therapeutic implications
 

Serge Erlinger